Louvain-la-Neuve, Belgium
Summary
This company specializes in the design, production, and marketing of innovative solutions for the diagnosis and treatment of cancer, utilizing advanced particle accelerator technology. Their offerings include proton therapy systems, dosimetry and quality assurance services, radioisotope production, and industrial applications such as medical device sterilization. The business targets healthcare providers and industrial clients, emphasizing a commitment to scientific advancement and patient care.
Based on content on iba-worldwide.com
standardimaging.com
Middleton, Wisconsin
Medical Physics and Radiation Therapy Equipment
novanta.com
New Brunswick, Canada
Technology solutions for medical and industrial applications.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
23.6 years — Since May 2001
Web Hosting
Platform
E-Mail Provider
Microsoft Office 365
NAICS Code
334517
SIC 4 Digit Code
3841
SIC 2 Digit Code
38
Industry
1. Healthcare technology and medical devices.
2. Irradiation Apparatus Manufacturing
Vendor
Source
Microsoft
TXT Record
Mandrill
TXT Record
Pardot
TXT Record
Salesforce
TXT Record
Mailchimp
TXT Record
Sendgrid
TXT Record
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2001 |
|
|
|
|
|
|
|
|
|
|
|
|
2002 |
|
|
|
|
|
|
|
|
|
|
|
|
2003 |
|
|
|
|
|
|
|
|
|
|
|
|
2004 |
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
2012 |
|
|
|
|
|
|
|
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|